Sign In
Buy GNPX
$0.720
-0.0153 (-2.08%)
At Close: Jun 03, 2026
MicroCap Rodeo Investor Conference Lineup for October 15 and 16, 2019
12:00pm, Tuesday, 15'th Oct 2019
AUSTIN, TX / ACCESSWIRE / October 15, 2019 / The MicroCap Rodeo's inaugural event is set for October 15, and 16 th , 2019 in Austin Texas at the Hilton downtown Austin. Focused on the best ideas conce
Supreme Court: Ginsburg treated for tumor on pancreas
11:12am, Saturday, 24'th Aug 2019
WASHINGTON (AP) — Justice Ruth Bader Ginsburg has completed radiation therapy for a cancerous tumor on her pancreas and there is no evidence of the disease remaining, according to the Supreme...
Sean Parker is nerding out on cancer research. And he’s doing it in style
08:35am, Tuesday, 09'th Jul 2019
The billionaire is catalyzing real scientific progress through his eponymous institute. He's also bringing glamour to a field largely unfamiliar with it.
Xconomy: Meet the X of the Year Finalists for the Xconomy Awards San Diego
03:00pm, Monday, 13'th May 2019
The Xconomy Awards categories weren’t enough to capture the full diversity of the San Diego life science community. So we at Xconomy created X of the Year
Xconomy: Meet the Xconomy Awards San Diego Digital Trailblazer Finalists
11:56am, Wednesday, 01'st May 2019
San Diego's prowess in computer science, medical devices, and life sciences makes it a natural hub of innovative digital health companies. The finalists
Nano Drug Delivery for Cancer, Dermatology, and Pain
05:28pm, Thursday, 10'th Jan 2019
They say good things come in small packages. Like Herve Villechaize, the French actor who played Tattoo on Fantasy Island. The idiom also applies to drugs. No, we’re not talking about the little env
Xconomy: For CAR-T Cancer Fighters in the Real World, Two Roads Diverge
08:11pm, Thursday, 03'rd Jan 2019
A generation ago, cancer treatments made from a patient's own living immune cells would have been science fiction. Now they're here. The first two
Immunotherapy Drugs Slow Skin Cancer That Has Spread to the Brain
04:17pm, Thursday, 23'rd Aug 2018
Melanoma is more likely than most cancers to spread to the brain, and once it gets there, fewer than 20 percent of patients survive one year with traditional treatments. Yet a new study offers a glin
The pharmaphorum ASCO 2018 daily bulletin -
01:38pm, Friday, 01'st Jun 2018
pharmaphorum is on-site at ASCO 2018 and will be delivering daily insight into all of the main conference
Xconomy: VCs Put More Dollars Into Exosomes as Codiak Bio Lands $76M
11:55am, Wednesday, 29'th Nov 2017
Codiak BioSciences, the startup run by former Biogen (NASDAQ: ]) research chief Doug Williams, has rung up its third big round of cash in two years. The
Harry Boxer’s three biotech-stock breakouts to watch
08:15pm, Thursday, 26'th Oct 2017
In focus: Abeona Therapeutics, Ignyta and Spectrum Pharmaceuticals.
Two-Pronged Immune Response Destroys Tumors
04:46pm, Monday, 24'th Oct 2016
Using a combination of four different therapies, researchers from MIT reveal a new treatment that destroys tumors in mice. Harnessing the body’s own immune system to destroy tumors is a tantalizing
Mutant Yeast Are Cranking Out Pharma's Next Superdrug
12:00pm, Thursday, 10'th Mar 2016
The offices of Adimab, a biotech company in New Hampshire, smell like bread. But nobody's baking anything. Instead, Adimab is using yeast to cure cancer.
Manhattan Scientifics and Senior Scientific
03:31pm, Wednesday, 21'st Jan 2015
In a previous article, we highlighted Manhattan Scientific (OTCMKTS:MHTX), a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in various fields, wit
Natural Toxins Combined with Synthetic Drugs Could Disarm Cancer, Drug-Resistant Bacteria
04:09pm, Tuesday, 12'th Feb 2013
Researchers at Rice University believe that combining natural toxins with man-made mirror drugs will create the drug equivalent of a one-two punch, “confusing” bacteria and cancer and preventing t
